Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistance
Nat Commun
.
2023 Feb 7;14(1):672.
doi: 10.1038/s41467-023-35852-2.
Authors
Julia Boshuizen
1
,
David W Vredevoogd
#
1
,
Oscar Krijgsman
#
1
,
Maarten A Ligtenberg
1
,
Stephanie Blankenstein
2
,
Beaunelle de Bruijn
1
,
Dennie T Frederick
3
,
Juliana C N Kenski
1
,
Mara Parren
1
,
Marieke Brüggemann
1
,
Max F Madu
2
,
Elisa A Rozeman
1
,
Ji-Ying Song
4
,
Hugo M Horlings
5
,
Christian U Blank
1
,
Alexander C J van Akkooi
2
,
Keith T Flaherty
6
,
Genevieve M Boland
3
,
Daniel S Peeper
7
Affiliations
1
Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
2
Division of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
3
Department of Surgical Oncology, Massachusetts General Hospital, Boston, MA, USA.
4
Division of Animal Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
5
Division of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
6
Department of Medical Oncology, Massachusetts General Hospital, Boston, MA, USA.
7
Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands. d.peeper@nki.nl.
#
Contributed equally.
PMID:
36750559
PMCID:
PMC9905532
DOI:
10.1038/s41467-023-35852-2
No abstract available
Publication types
Published Erratum